FOXD1 and pancreatic adenocarcinoma: We further found that overexpression of FOXD1 generally predicts poor prognosis in tumors with high FOXD1 expression, such as ACC, READ, MESO, LGG, UVM, PAAD, KIRC, HNSC, SARC, and BLCA.